The consensus statement from the NF1 Optic Pathway Glioma Task Force in 2004 acknowledged that radiotherapy has the longest experience with the treatment of OPGs and addressed the pros and cons of radiotherapy [9]. This evidence concerns the gene NF1 and glioma.